| 12213987 |
Prodrug salts |
Marc F. Pelletier, Paul Robert McGuirk, George William Farr, Robert Zamboni, Helmi Zaghdane |
2025-02-04 |
|
| 11071744 |
Prodrug salts |
Marc F. Pelletier, Paul Robert McGuirk, George William Farr, Robert Zamboni, Helmi Zaghdane |
2021-07-27 |
|
| 10258636 |
Prodrug salts |
Marc F. Pelletier, Paul Robert McGuirk, George William Farr, Robert Zamboni, Helmi Zaghdane |
2019-04-16 |
|
| 10035813 |
Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
John J. Partridge, Yves Gareau, Michel Therien, Robert Zamboni, Barry Hafkin +2 more |
2018-07-31 |
|
| 9827253 |
Prodrug salts |
Marc F. Pelletier, Paul Robert McGuirk, George William Farr, Robert Zamboni, Helmi Zaghdane |
2017-11-28 |
|
| 9334295 |
Fused aromatic PTP-1B inhibitors |
Marie-Claire Wilson, Yongxin Han, Claude Dufresne, Michel Belley, Cheuk K. Lau +1 more |
2016-05-10 |
|
| 9023864 |
Indole derivatives as CRTH2 receptor antagonists |
Carl Berthelette, Michael Boyd, Karine Villeneuve, Joey L. Methot |
2015-05-05 |
$66,112,000 |
| 8927526 |
Fused aromatic PTP-1B inhibitors |
Marie-Claire Wilson, Yongxin Han, Claude Dufresne, Michel Belley, Cheuk K. Lau +1 more |
2015-01-06 |
|
| 8901105 |
Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
John J. Partridge, Yves Gareau, Michel Therien, Robert Zamboni, Barry Hafkin +2 more |
2014-12-02 |
|
| 8637671 |
Indole derivatives as CRTH2 receptor antagonists |
Michael Boyd, Mohamed Helmi Zaghdane, Michel Gallant |
2014-01-28 |
|
| 8481742 |
Fused aromatic PTP-1B inhibitors |
Marie-Claire Wilson, Yongxin Han, Claude Dufresne, Michel Belley, Cheuk K. Lau +1 more |
2013-07-09 |
|
| 8394819 |
Indole derivatives as CRTH2 receptor antagonists |
Carl Berthelette, Michael Boyd, Karine Villeneuve, Joey L. Methot |
2013-03-12 |
$65,416,000 |
| 8168815 |
Fused aromatic PTP-1B inhibitors |
Marie-Claire Wilson, Yongxin Han, Claude Dufresne, Michel Belley, Cheuk K. Lau +1 more |
2012-05-01 |
|
| 8158671 |
Indole and indoline cyclopropyl amide derivatives as EP4 receptor antagonists |
Michael Boyd, Yongxin Han |
2012-04-17 |
|
| 8013159 |
Quinoline derivatives as EP4 antagonists |
Michel Belley, Jason Burch, Julie Farand, Mario Girard, Yongxin Han |
2011-09-06 |
|
| RE42562 |
EP4 receptor agonist, compositions and methods thereof |
Xavier Billot, Robert N. Young, Yongxin Han, Marie-Claire Wilson |
2011-07-19 |
|
| 7968578 |
Indole amide derivatives as EP4 receptor antagonists |
Michael Boyd, Zhaoyin Wang |
2011-06-28 |
$60,499,000 |
| 7705035 |
Indoline amide derivatives as EP4 receptor ligands |
Michael Boyd |
2010-04-27 |
$81,671,000 |
| 7238710 |
EP4 receptor agonist, compositions and methods thereof |
Xavier Billot, Yongxin Han, Marie-Claire Wilson, Robert N. Young |
2007-07-03 |
$81,678,000 |
| 7109223 |
Oxazolidin-2-one and thiazolidin-2-one derivatives for use as EP4 receptor agonists in the treatment of glaucoma |
Yongxin Han, Xavier Billot, Marie-Claire Wilson, Robert N. Young |
2006-09-19 |
$69,070,000 |
| 7053085 |
EP4 receptor agonist, compositions and methods thereof |
Xavier Billot, Yongxin Han, Marie-Claire Wilson, Robert N. Young |
2006-05-30 |
$88,964,000 |
| 6699856 |
Pyrazinones, compositions containing such compounds and methods of use |
Yongxin Han, Andre Giroux, Robert Zamboni, Daniel McKay, Christopher Bayly +1 more |
2004-03-02 |
$103,914,000 |
| 6444811 |
Pyrazinones, compositions containing such compounds and methods of use |
Yongxin Han, Andre Giroux, Robert Zamboni, Daniel McKay, Christopher Bayly +1 more |
2002-09-03 |
$154,700,000 |
